Domov › Nemalicelični pljučni rak › Ohio › Akron
Klinične študije za Nemalicelični pljučni rak v Akron, OH
22 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Akron in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · 21 mi stran
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Vključevanje udeležencevFaza 3
- Aultman Health Foundation, Canton · 21 mi stran
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Vključevanje udeležencevFaza 3
- Akron General Medical Center, Akron
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Aultman North, North Canton · 15 mi stran
- Aultman Massillon, Massillon · 20 mi stran
- Aultman Orrville Hospital, Orrville · 21 mi stran
- in še 2
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Canton · 21 mi stran
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Aultman Hospital, Canton · 21 mi stran
Pan-tumor MRD Study
Vključevanje udeležencevOpazovalna študija
- Gabrail Cancer Center, Canton · 21 mi stran
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Vključevanje udeležencevFaza 2/3
- Gabrail Cancer Center Research, Canton · 21 mi stran
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
Vključevanje udeležencevFaza 2
- Gabrail Cancer Center, Canton · 21 mi stran
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Vključevanje udeležencevFaza 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · 20 mi stran
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Vključevanje udeležencevFaza 1/2
- Gabrail Cancer Center Research, Canton · 21 mi stran
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Gabrail Cancer Center, Canton · 21 mi stran
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Vključevanje udeležencevFaza 2
- Gabrail Cancer and Research Center, Canton · 21 mi stran
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Cleveland Clinic Mercy Hospital, Canton · 21 mi stran
- Aultman Health Foundation, Canton · 21 mi stran
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Aultman Health Foundation, Canton · 21 mi stran
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Aultman Health Foundation, Canton · 21 mi stran
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Aultman Health Foundation, Canton · 21 mi stran
GEMINI-NSCLC: NSCLC Biomarker Study
Vključevanje udeležencevOpazovalna študija
- Aultman Hospital, Canton · 21 mi stran
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Gabrail Cancer & Research Center, Canton · 21 mi stran
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Research Site 138, Canton · 21 mi stran
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Vključevanje udeležencevFaza 1/2
- Gabrail Cancer Center Research, Canton · 21 mi stran
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Vključevanje udeležencevFaza 1/2
- Gabrail Cancer Research Center, Canton · 21 mi stran
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY120 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH56 študij
- Washington, DC55 študij
Druge študije v Akron
- Rak pljuč16 študij
- Rak (vse vrste)13 študij
- Rak dojke13 študij
- Rak prostate9 študij
- Akutna mieločna levkemija8 študij
- Melanom8 študij
- Mikrocitni rak pljuč8 študij
- Metastatski rak8 študij
- Kolorektalni rak8 študij
- Steatotična bolezen jeter7 študij
- Rak endometrija6 študij
- Rak jajčnikov6 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.